aadibio.com (AADI): Projected Future Earnings

Public company logo of Aadi Bioscience (AADI)

The development of Aadi Bioscience (AADI) was driven by orphan drug status and PRECISION1 trials, which created a peak on the chart. Expected marginal profit is currently holding around . Growth is based on nanoparticles for mTOR suppression. Business stability is ensured by the neutrality of biomedicine in global conflicts, minimizing external risks for investors.

AADI - Aadi Bioscience Expected Net Profit over the range 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Aadi Bioscience Inc (AADI)

- price and consensus price forecast:
Price Chart Aadi Bioscience Inc|AADI - Average Forecast Price
- stock exchange capitalization data:
Market Capitalization Aadi Bioscience Inc|AADI - Full Takeover Company Value
- book capitalization indicators:
Accounting Value per Share Aadi Bioscience|AADI - Total Stockholders' Equity|Market Cap to Net Assets Ratio aadibio.com|AADI - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Equity Ratio Aadi Bioscience|AADI - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Aadi Bio|AADI - Company Aggregate Debts|Debt to Book Capitalization Ratio Aadi Bio|AADI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Aadi Bioscience|Quick Ratio aadibio.com
- earnings and market ratios statistics:
AADI - Company Net Income|Future Profit Aadi Bioscience|AADI - Market Price to Net Income Ratio|Forward P/E Multiple Aadi Bioscience Inc|AADI - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple AADI|AADI - Operating profit before amortization|Net earnings per share for the last 12 months Aadi Bioscience|AADI - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months aadibio.com|AADI - Net earnings per one share growth for the current year|Earnings growth forecast for next year Aadi Bioscience
- total revenue and sales volume data:
AADI - Company Sales Revenue|Projected Sales Volume Aadi Bioscience Inc|AADI - Price to Sales|Price-to-Projected Revenue Ratio Aadi Bio
Basic company analysis:AADI, Aadi Bioscience Inc
Brand item of Aadi Bioscience, Inc.

Projected profit represents an aggregated assessment of future cash flows based on analyst consensus. This metric measures the resilience of expected earnings against external regulatory shocks and market volatility. An analytical profit forecast allows for an objective determination of an asset's pivot point, eliminating emotional buying. For Aadi Bioscience (AADI), this indicator is critical, as the company focuses on individual clinical trials for oncology drugs. The absence of a merger strategy makes this calculation the sole filter for the business's real value.

Competitor analysis for Aadi Bioscience

Expected Profit Genmab Corp|Expected Net Profit Exelixis EXEL|Projected Future Earnings NUVL|Kymera Therapeutics (KYMR) - Projected Net Profit|IDEAYA Biosciences Inc - Future Profit|Enliven Therapeutics, Inc. (ELVN) - Expected Net Profit|ORIC: Future Profit|Expected Net Income RLAY (Relay Pharma)|NRIX (Nurix Therapeutics, Inc.) - Future Profit|TYRA: Future Net Profit|VSTM (Verastem Corp) - Projected Future Earnings|Projected Future Earnings monterosatx.com|Expected Profit Cullinan Therapeutics, Inc. (CGEM)|IMRX (Immuneering) - Expected Net Income|Projected Future Earnings CCCC (C4 Therapeutics Inc)|Projected Net Profit Black Diamond Therapeutics Inc.|Repare Therapeutics, Inc. - Projected Future Earnings|Expected Net Profit PMV Pharmaceuticals, Inc.|KPTI (karyopharm.com) - Future Profit|PPCB: Future Net Profit|BGMS (cyclacel.com) - Projected Future Earnings|Expected Net Profit Aileron Therapeutics ALRN|Projected Future Earnings BPMC|GlycoMimetics Corp - Net Profit Forecast|SpringWorks Therapeutics, Inc. - Future Profit